Parallax Health Sciences seeks to obtain FDA approval for Fotodigm platform

Image: Parallax plans to file an application with the US Food and Drug Administration (FDA). Photo: Courtesy of The U.S. Food and Drug Administration/Wikipedia.



Related Article
Recommended Whitepaper

View More